Amazon’s Former Prime Boss, Moved To Strategic Health Role

0
Amazon’s Former Prime Boss, Moved To Strategic Health Role
ckstockphoto / Pixabay

Amazon.com, Inc. (NASDAQ:AMZN) has placed former Prime boss Neil Lindsay in the role of senior vice president of health. Lindsay will be in charge of supervising health care activities as the e-commerce giant is looking to increase its presence in this industry.

Get The Full Walter Schloss Series in PDF

Get the entire 10-part series on Walter Schloss in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

Q3 2021 hedge fund letters, conferences and more

Seth Klarman’s 2021 Letter: Baupost’s “Never-Ending” Hunt For Information

Baupost's investment process involves "never-ending" gleaning of facts to help support investment ideas Seth Klarman writes in his end-of-year letter to investors. In the letter, a copy of which ValueWalk has been able to review, the value investor describes the Baupost Group's process to identify ideas and answer the most critical questions about its potential Read More

Appointment

As informed by CNBC, the former head of Amazon Prime has been moved to a role that can be considered strategic for the company. As Amazon is intending to increase its presence within the healthcare sector, it is also boosting online pharmacy and telehealth services amid the Covid pandemic.

According to a source, Lindsay’s responsibilities “now include overseeing Amazon’s combined health care efforts, including its online pharmacy, telehealth, and health diagnostics units, according to a person familiar with the matter. He continues to oversee Amazon’s global brand and marketing efforts.”

Lindsay has been part of Amazon for about 11 years and has been instrumental in the growth of key company fronts. He is recognized as a marketing ace and headed the firm’s Prime subscription unit to great success.

He also played a key role in shaping the Kindle e-reader brand and was also instrumental in the branding of Echo and Fire products.

Strategic Market

Amazon’s bet on the healthcare industry started with the launch of Amazon Pharmacy in 2020, whose objective is to allow customers to order prescriptions through the platform —this was facilitated by Amazon’s acquisition of PillPack in 2018 for $753 million.

The e-commerce giant is on the hunt for the $500 billion people spend on prescription medications in the U.S., according to IQVIA. Almost 60% of American adults suffer from one chronic disease —heart disease, cancer, or diabetes— and 40% have two or more, as revealed by the Centers for Disease Control and Prevention (CDC).

CNBC informs that the retail drug market for prescriptions has been controlled by large pharmacy chains such as CVS Health Corp (NYSE:CVS) and Walgreens Boots Alliance Inc (NASDAQ: WBA).

Independent pharmacies also have a good share of the market, and “all count on a few middlemen known as pharmacy benefit managers (PBMs) to negotiate prices, as well as a handful of large drug distributors.”

Amazon is part of the Entrepreneur Index, which tracks 60 of the largest publicly traded companies managed by their founders or their founders' families.

Updated on

Cristian Bustos is senior editor for ValueWalk.com. Previously, he was the news correspondent in Germany for Colombian radio broadcast Blu Radio, where he covered the 2017 German federal election and the 2017 G20 Hamburg summit. He was also public relations consultant to EY and HAYS, and has covered a wide range of topics including business, finance, and international relations, as well as verticals such as automotive, aerospace and renewable energy. Email him at [email protected]
Previous article Walmart Black Dolls Found To Be More Expensive Than White Dolls
Next article Industry Reaction To BoE’s Interest Rates Increase

No posts to display